Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma

International Journal of Cancer

Volumn 134, Issue 5, 2014, Pages 1207-1213

  Bidard, François Clément ^a   Madic, Jordan ^b   Mariani, Pascale ^a   Piperno Neumann, Sophie ^a   Rampanou, Aurore ^a,b   Servois, Vincent ^a   Cassoux, Nathalie ^a   Desjardins, Laurence ^a   Milder, Maud ^a   Vaucher, Isabelle ^a   Pierga, Jean Yves ^a,c   Lebofsky, Ronald ^a   Stern, Marc Henri ^a,b   Lantz, Olivier ^a,d  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

circulating tumor cells; circulating tumor DNA; metastasis; uveal melanoma

Indexed keywords

CIRCULATING TUMOR DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIDIRECTIONAL PYROPHOSPHOROLYSIS ACTIVATED POLYMERIZATION; CANCER DIAGNOSIS; CANCER TISSUE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE DOSAGE; GENE MUTATION; GNA11 GENE; GNAQ GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; METASTATIC UVEAL MELANOMA; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERIZATION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; TUMOR GENE; UVEA MELANOMA;

CIRCULATING TUMOR CELLS; CIRCULATING TUMOR DNA; METASTASIS; UVEAL MELANOMA;

ADOLESCENT; ADULT; DNA, NEOPLASM; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; UVEAL NEOPLASMS;

EID: 84890564614     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28436     Document Type: Article

References (30)

1. Virgili G, Gatta G, Ciccolallo L, et al. Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309-15.
2. Singh AD, Topham A,. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110: 956-61.
3. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599-602.
4. Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363: 2191-9.
5. Ambrosini G, Pratilas CA, Qin L-X, et al. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance. Clin Cancer Res 2012; 18: 3552-61.
6. Mariani P, Servois V, Piperno-Neumann S,. Therapeutic options in metastatic uveal melanoma. Dev Ophthalmol 2012; 49: 166-81.
7. Paget S,. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
8. Bidard Pierga J-Y, Soria J-C, Thiery JP,. Translating metastasis-related biomarkers to the clinic-progress and pitfalls. Nat Rev Clin Oncol 2013; 10: 169-79.
9. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
10. Pierga J-Y, Hajage D, Bachelot T, et al. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann Oncol 2012; 23: 618-24.
11. Bidard F-C, Belin L, Delaloge S, et al. Time-dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: 70-month analysis of the REMAGUS02 study. Int J Breast Cancer 2013; 2013: 130470.
12. Bidard FC, Ferrand FR, Huguet F, et al. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2012; 82: 103-15.
13. Scher HI, Jia X, de Bono JS, et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 2009; 10: 233-9.
14. Bidard FC, Huguet F, Louvet C, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol 2013; 24: 2027-61.
15. Khan MS, Kirkwood A, Tsigani T, et al. Circulating tumor cells as prognostic markers in neuroendocrine tumors. J Clin Oncol 2013; 31: 365-72.
16. Bidard F-C, Fehm T, Ignatiadis M, et al. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials. Cancer Metastasis Rev 2013; 32: 179-88.
17. Rao C, Bui T, Connelly M, et al. Circulating melanoma cells and survival in metastatic melanoma. Int J Oncol 2011; 38: 755-60.
18. Khoja L, Lorigan P, Zhou C, et al. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma. J Invest Dermatol 2013; 133: 1582-90.
19. Schwarzenbach H, Hoon DSB, Pantel K,. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-37.
20. Madic J, Piperno-Neumann S, Servois V, et al. Pyrophosphorolysis- activated polymerization detects circulating tumor DNA in metastatic uveal melanoma. Clin Cancer Res 2012; 18: 3934-41.
21. Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol 2009; 35: 1192-7.
22. Li Y, Madigan MC, Lai K, et al. Human uveal melanoma expresses NG2 immunoreactivity. Br J Ophthalmol 2003; 87: 629-32.
23. Ulmer A, Beutel J, Süsskind D, et al. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma. Clin Cancer Res 2008; 14: 4469-74.
24. Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14: 985-90.
25. Rago C, Huso DL, Diehl F, et al. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 2007; 67: 9364-70.
26. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180-4.
27. Schwarzenbach H, Alix-Panabières C, Müller I, et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009; 15: 1032-8.
28. Van der Auwera I, Elst HJ, Van Laere SJ, et al. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer 2009; 100: 1277-86.
29. Suesskind D, Ulmer A, Schiebel U, et al. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study. Acta Ophthalmol 2011; 89: 17-24.
30. Eide N, Hoifødt HK, Nesland JM, et al. Disseminated tumour cells in bone marrow of patients with uveal melanoma. Acta Ophthalmol 2013; 91: 343-8.